ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$5.71
Tradestie Score
55
Market Cap
$1.78B
Revenue Growth
1.0%
Analyst Upside
+83.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LQDA
Liquidia Corporation Common Stock
|
$84.11
|
$1.90B | 510.6 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.10
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$33.81
|
$1.81B | - | 51 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.18
|
$1.78B | - | 55 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.92
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.06
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$3.91
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.43
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.50
|
$1.57B | - | 51 | Compare |
|
SDGR
Schrodinger, Inc. Common Stock
|
$15.14
|
$1.56B | - | 46 | Compare |
More ABCL Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry